pharma · Acute Myeloid Leukemia · Breast Cancer
First People's Hospital
The First People's Hospital of Lianyungang
First People's Hospital is a pharma organization headquartered in SAN DIEGO, CA, CN. Primary therapeutic focus areas include Acute Myeloid Leukemia, Breast Cancer, Gastric Cancer, Multiple Myeloma, Esophageal Squamous Ce
SAN DIEGO, CA, CN HQ
NMPA registrant Type
Company details
- Status
- Public
- HQ
- SAN DIEGO, CA, CN
- Programs
- 1136
- Drugs
- 626
- Patents
- 123
Capecitabine-Oxaliplatin-Irinotecan Combination
Phase 2 · small molecule · Unresectable Metastatic Colorectal Cancer
Capecitabine-Oxaliplatin-Irinotecan Combination for Unresectable Metastatic Colorectal Cancer is a Phase 2 program (small_molecule) at The First People's Hospital of Lianyungang with 1 ClinicalTrials.gov record(s).
Internal code TRICAP
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- The First People's Hospital of Lianyungang
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Unresectable Metastatic Colorectal Cancer
- Status
- active
- Trials
- 1